Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response 
What You Should Know:Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the…
Continue Reading